Skip to main content
. 2017 Apr 5;96(4):929–934. doi: 10.4269/ajtmh.16-0727

Table 3.

Characteristics of 710 Boston Area Travel Medicine Network pre-travel participants in Group 3* and seropositivity status for IgG antibodies against hepatitis E (anti-HEV IgG)

Characteristics Anti-HEV IgG (+) (N = 48), N (%) Anti-HEV IgG (−) (N = 662), N (%) Bivariate prevalence odds ratio (95% CI) Multivariate prevalence odds ratio (95% CI)
Country of birth
 United States 38 (79) 538 (81) Referent Referent
 Other 10 (21) 124 (19) 1.1 (0.6–2.3) 0.7 (0.2–2.6)
Sex
 Male 21 (44) 306 (46) Referent Referent
 Female 26 (54) 355 (54) 1.1 (0.6–1.9) 1.2 (0.5–2.5)
Number of highly endemic countries traveled to
 1–2 countries 23 (48) 460 (69) Referent Referent
 Three or more countries 25 (52) 202 (31) 2.5 (1.4–4.5) 2.7 (1.2–5.9)
Race
 Non-white 2 (4) 114 (18) Referent Referent
 White 45 (94) 521 (82) 4.9 (1.2–20.6) 3.8 (0.5–30.2)
Age
 < 20 years 0 (0) 17 (3) Excluded Excluded
 20–40 years 5 (10) 204 (31) Referent Referent
 > 40 years 24 (50) 203 (31) 4.8 (1.8–12.) 3.7 (1.3–10.2)
 Missing 19 (40) 238 (36) Excluded Excluded

CI = confidence interval.

*

Group 3 travelers were not born in, and never lived in, a country highly endemic for hepatitis E but traveled to a highly endemic country.

Multivariate analysis included 419 participants; participants with missing values for any variable and/or who were younger than 20 years of age at the time of enrollment were excluded. Hosmer and Lemeshow goodness-of-fit test showed that the model fit well (P = 0.87).